Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 1
2009 1
2010 1
2013 2
2015 3
2016 2
2018 3
2019 6
2020 1
2021 5
2022 1
2023 4
2024 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial.
Villanueva C, Albillos A, Genescà J, Garcia-Pagan JC, Calleja JL, Aracil C, Bañares R, Morillas RM, Poca M, Peñas B, Augustin S, Abraldes JG, Alvarado E, Torres F, Bosch J. Villanueva C, et al. Among authors: penas b. Lancet. 2019 Apr 20;393(10181):1597-1608. doi: 10.1016/S0140-6736(18)31875-0. Epub 2019 Mar 22. Lancet. 2019. PMID: 30910320 Clinical Trial.
[Entecavir].
Calleja JL, Peñas B. Calleja JL, et al. Among authors: penas b. Enferm Infecc Microbiol Clin. 2008 May;26 Suppl 7:39-48. doi: 10.1016/s0213-005x(08)76518-2. Enferm Infecc Microbiol Clin. 2008. PMID: 19100230 Review. Spanish.
Metabolomics as a tool to predict the risk of decompensation or liver-related death in patients with compensated cirrhosis.
Nicoară-Farcău O, Lozano JJ, Alonso C, Sidorova J, Villanueva C, Albillos A, Genescà J, Llop E, Calleja JL, Aracil C, Bañares R, Morillas R, Poca M, Peñas B, Augustin S, Tantău M, Thompson M, Perez-Campuzano V, Baiges A, Turon F, Hernández-Gea V, Abraldes JG, Tapias EA, Torres F, Bosch J, García-Pagán JC; PreDesCI Study Investigators. Nicoară-Farcău O, et al. Among authors: penas b. Hepatology. 2023 Jun 1;77(6):2052-2062. doi: 10.1097/HEP.0000000000000316. Epub 2023 Feb 23. Hepatology. 2023. PMID: 36811400 Clinical Trial.
Endoscopic surveillance for familial intestinal gastric cancer in low-incidence areas: An effective strategy.
Llach J, Salces I, Guerra A, Peñas B, Rodriguez-Alcalde D, Redondo PD, Cubiella J, Murcia Ó, Escalante M, Gratacós-Ginès J, Pocurull A, Daca-Alvarez M, Luzko I, Sánchez A, Herrera-Pariente C, Ocaña T, Carballal S, Elizalde I, Castellví-Bel S, Fernández-Esparrach G, Castells A, Balaguer F, Moreira L. Llach J, et al. Among authors: penas b. Int J Cancer. 2024 Jan 1;154(1):124-132. doi: 10.1002/ijc.34714. Epub 2023 Sep 7. Int J Cancer. 2024. PMID: 37676082
Clinical outcomes of anti-reflux mucosal ablation for gastroesophageal reflux disease: An international bi-institutional study.
Shimamura Y, Inoue H, Tanabe M, Ushikubo K, Yamamoto K, Kimoto Y, Nishikawa Y, Ando R, Sumi K, Navarro MJ, Teruel Sanchez-Vegazo C, Peñas B, Parejo S, Martínez Sánchez A, Vazquez-Sequeiros E, Onimaru M, Albillos A, Rodriguez de Santiago E. Shimamura Y, et al. Among authors: penas b. J Gastroenterol Hepatol. 2024 Jan;39(1):149-156. doi: 10.1111/jgh.16370. Epub 2023 Oct 3. J Gastroenterol Hepatol. 2024. PMID: 37787176
Antireflux mucosectomy (ARMS) and antireflux mucosal ablation (ARMA) for gastroesophageal reflux disease: a systematic review and meta-analysis.
Rodríguez de Santiago E, Sanchez-Vegazo CT, Peñas B, Shimamura Y, Tanabe M, Álvarez-Díaz N, Parejo S, Kazuya S, Marcos-Carrasco N, Vazquez-Sequeiros E, Inoue H, Albillos A. Rodríguez de Santiago E, et al. Among authors: penas b. Endosc Int Open. 2021 Nov 12;9(11):E1740-E1751. doi: 10.1055/a-1552-3239. eCollection 2021 Nov. Endosc Int Open. 2021. PMID: 34790538 Free PMC article. Review.
Exploring algorithms to select candidates for non-selective beta-blockers in cirrhosis: A post hoc analysis of the PREDESCI trial.
Dajti E, Villanueva C, Berzigotti A, Brujats A, Albillos A, Genescà J, García-Pagán JC, Colecchia A, Bosch J; PREDESCI trial investigators; A study by the Baveno Cooperation, an EASL Consortium. Dajti E, et al. J Hepatol. 2024 Sep 19:S0168-8278(24)02553-4. doi: 10.1016/j.jhep.2024.09.014. Online ahead of print. J Hepatol. 2024. PMID: 39303875 Free article.
Serum miR-181b-5p predicts ascites onset in patients with compensated cirrhosis.
Garcia Garcia de Paredes A, Villanueva C, Blanco C, Genescà J, Manicardi N, Garcia-Pagan JC, Calleja JL, Aracil C, Morillas RM, Poca M, Peñas B, Augustin S, Abraldes JG, Alvarado E, Royo F, Garcia-Bermejo ML, Falcon-Perez JM, Bañares R, Bosch J, Gracia-Sancho J, Albillos A. Garcia Garcia de Paredes A, et al. Among authors: penas b. JHEP Rep. 2021 Sep 27;3(6):100368. doi: 10.1016/j.jhepr.2021.100368. eCollection 2021 Dec. JHEP Rep. 2021. PMID: 34712934 Free PMC article.
26 results